0001140361-21-010380.txt : 20210329
0001140361-21-010380.hdr.sgml : 20210329
20210329070034
ACCESSION NUMBER: 0001140361-21-010380
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210325
FILED AS OF DATE: 20210329
DATE AS OF CHANGE: 20210329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chambers Rebecca
CENTRAL INDEX KEY: 0001823563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39513
FILM NUMBER: 21779431
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DR.
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outset Medical, Inc.
CENTRAL INDEX KEY: 0001484612
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 200514392
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 669-231-8200
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
FORMER COMPANY:
FORMER CONFORMED NAME: Home Dialysis Plus, Ltd.
DATE OF NAME CHANGE: 20100219
4
1
form4.xml
FORM 4
X0306
4
2021-03-25
0001484612
Outset Medical, Inc.
OM
0001823563
Chambers Rebecca
3052 ORCHARD DRIVE
SAN JOSE
CA
95134
true
Chief Financial Officer
Common Stock
2021-03-25
4
M
0
16727
6.25
A
30324
D
Common Stock
2021-03-25
4
S
0
3592
49.1133
D
26732
D
Common Stock
2021-03-25
4
S
0
13135
50.1639
D
13597
D
Stock Option (Right to Buy)
6.25
2021-03-25
4
M
0
16727
0
D
2029-09-10
Common Stock
16727
127926
D
This option vests 25% on June 3, 2020, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.62 to $49.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $49.68 to $51.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
This Form 4 corrects the exercise price previously reported as $6.24 on the Form 3 filed on September 14, 2020.
/s/ Rebecca Chambers
2021-03-26